Key New Findings for Follicular Lymphoma Treatment

According to two new studies published online August 1 in the Journal of Clinical Oncology, bortezomib in combination with rituximab, cyclophosphamide, vincristine, and prednisone (BR-CVP) could be effectively utilized to battle advanced-stage follicular lymphoma in patients.

For the purposes of their study, Laurie H. Sehn, M.D., M.P.H., from the National Cancer Institute of Canada Clinical Trials Group in Kingston, analyzed her findings among 84 patients with newly diagnosed stage III follicular lymphoma. The researchers involved noted that BR-CVP was handled mostly well, with 90 percent of participants completing eight treatment cycles. Of that group, only five patients developed grade 3 neurotoxicity, and none developed grade 4 neurotoxicity. A complete response was seen in 49 percent of patients and a partial response was seen in 34 percent.

In the other study, Nathan Fowler, M.D., from the Anderson Cancer Center in Houston investigated the effectiveness and toxicity of bortezomib, bendamustine, and rituximab. For the purposes of this study, 63 patents with follicular lymphoma were sought out. An overall response rate of 88 percent was noted, with 53 percent showing a complete response.

"The combination of bortezomib, bendamustine, and rituximab is highly active in patients with follicular lymphoma who have received previous treatment," Fowler and colleagues conclude.

More Articles

More Articles

Mantle cell lymphoma (MCL) is a rare type of B-Cell lymphoma. It presents itself in the mantle zone of lymph nodes...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

Indolent Lymphoma, or Indolent Non-Hodgkin’s Lymphomas (NHLs), are slow growing, low-grade cancers (as opposed to ...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

Lymphomas are classified based on the type of cells involved. Non-Hodgkin’s lymphomas are marked by mutations of...

Hodgkin's Lymphoma (Disease) has a colorful history: It was not the first cancer discovered but it was one of the first in which treatments were...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

Cancer bracelets are undeniably popular, and if purchased through reliable sources such as major charities, they help contribute to the fight...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Lymphoma is a cancer of the b- and t-cell lymphocytes, part of the immune system. They account for the most frequent head and neck malignancies....

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...

As a kind of cancer, lymphoma attacks the lymphocytes and lymph nodes that are part of the immune system. Head and neck lymphoma results when...

Some cancers have clear environmental causes. Oral cancer is strongly tied to the use of chewing tobacco, and lung cancer is well-known to be much...

The Follicular Lymphoma International Prognostic Index, or FLIPI, is a standardized guide to help oncological diagnosticians accurately calculate...